• Andreou, A.Z., Harms, U.,Klostermeier, D., 2017. eIF4B stimulates eIF4A ATPase and unwinding activities by direct interaction through its 7-repeats region. RNA Biol, 14, 113-123.

  • Bang, B.R., Li, M., Tsai, K.N., Aoyagi, H., Lee, S.A., Machida, K., Aizaki, H., Jung, J.U., Ou, J.J.,Saito, T., 2019. Regulation of Hepatitis C Virus Infection by Cellular Retinoic Acid Binding Proteins through the Modulation of Lipid Droplet Abundance. J Virol, 93.

  • Bartholomeeusen, K., Daniel, M., Labeaud, D.A., Gasque, P., Peeling, R.W., Stephenson, K.E., Ng, L.F.P.,Arien, K.K., 2023. Chikungunya fever. Nat Rev Dis Primers, 9, 17.

  • Bhardwaj, U., Powell, P.,Goss, D.J., 2019. Eukaryotic initiation factor (eIF) 3 mediates Barley Yellow Dwarf Viral mRNA 3'-5' UTR interactions and 40S ribosomal subunit binding to facilitate cap-independent translation. Nucleic Acids Res, 47, 6225-6235.

  • Burgess, H.M., Vink, E.I.,Mohr, I., 2022. Minding the message: tactics controlling RNA decay, modification, and translation in virus-infected cells. Genes Dev, 36, 108-132.

  • Cortes, N., Lira, A., Prates-Syed, W., Dinis Silva, J., Vuitika, L., Cabral-Miranda, W., Duraes-Carvalho, R., Balan, A., Cabral-Marques, O.,Cabral-Miranda, G., 2023. Integrated control strategies for dengue, Zika, and Chikungunya virus infections. Front Immunol, 14, 1281667.

  • De Almeida, M.T., Merighi, D.G.S., Visnardi, A.B., Boneto Goncalves, C.A., Amorim, V.M.F., Ferrari, A.S.A., De Souza, A.S.,Guzzo, C.R., 2025. Latin America's Dengue Outbreak Poses a Global Health Threat. Viruses, 17.

  • De Lima Cavalcanti, T.Y.V., Pereira, M.R., De Paula, S.O.,Franca, R.F.O., 2022. A Review on Chikungunya Virus Epidemiology, Pathogenesis and Current Vaccine Development. Viruses, 14.

  • Ding, C., Tang, W., Xia, B., Peng, H., Liu, Y., Wang, J., Zheng, X., Liu, Y., Zhao, L., He, Y., Qi, Z., Ren, H., Tang, H.,Zhao, P., 2022. High-Throughput Screening of FDA-Approved Drug Library Reveals Ixazomib Is a Broad-Spectrum Antiviral Agent against Arboviruses. Viruses, 14.

  • Feng, F., Bouma, E.M., Hu, G., Zhu, Y., Yu, Y., Smit, J.M., Diamond, M.S.,Zhang, R., 2023. Colocalization of Chikungunya Virus with Its Receptor MXRA8 during Cell Attachment, Internalization, and Membrane Fusion. J Virol, 97, e0155722.

  • Freppel, W., Silva, L.A., Stapleford, K.A.,Herrero, L.J., 2024. Pathogenicity and virulence of chikungunya virus. Virulence, 15, 2396484.

  • Han, J.,Jang, K.L., 2023. All-trans Retinoic Acid Inhibits Hepatitis B Virus Replication by Downregulating HBx Levels via Siah-1-Mediated Proteasomal Degradation. Viruses, 15.

  • He, Y., Pan, Z., Liu, Y., Jiang, L., Peng, H., Zhao, P., Qi, Z., Liu, Y.,Tang, H., 2023. Identification of tyrphostin AG879 and A9 inhibiting replication of chikungunya virus by screening of a kinase inhibitor library. Virology, 588, 109900.

  • He, Z., Chen, Y., Xia, B., Cheng, Z., Zhao, P., Qi, Z.,Zhu, Y., 2025. CC-90009, a Cereblon E3 Ligase Modulator, Exhibits Antiviral Efficacy Against JEV In Vitro and In Vivo via Targeted Degradation of GSPT1 and Viral NS5 Protein. Pharmaceutics, 17.

  • Jiang, S., Li, H., Zhang, L.,Al., E., 2025. Generic DiagrammingPlatform (GDP): a comprehensive database of high-quality biomedical graphics. Nucleic Acids Res, 53, D1670-D1676.

  • Khongwichit, S., Chansaenroj, J., Chirathaworn, C.,Poovorawan, Y., 2021. Chikungunya virus infection: molecular biology, clinical characteristics, and epidemiology in Asian countries. J Biomed Sci, 28, 84.

  • Law, M.C.Y., Zhang, K., Tan, Y.B., Nguyen, T.M.,Luo, D., 2023. Chikungunya virus nonstructural protein 1 is a versatile RNA capping and decapping enzyme. J Biol Chem, 299, 105415.

  • Liang, C., Qiao, G., Liu, Y., Tian, L., Hui, N., Li, J., Ma, Y., Li, H., Zhao, Q., Cao, W., Liu, H.,Ren, X., 2021. Overview of all-trans-retinoic acid (ATRA) and its analogues: Structures, activities, and mechanisms in acute promyelocytic leukaemia. Eur J Med Chem, 220, 113451.

  • Liang, G., Gao, X.,Gould, E.A., 2015. Factors responsible for the emergence of arboviruses; strategies, challenges and limitations for their control. Emerg Microbes Infect, 4, e18.

  • Merrick, W.C., 2015. eIF4F: a retrospective. J Biol Chem, 290, 24091-24099.

  • Ng, L.F.P.,Renia, L., 2024. Live-attenuated chikungunya virus vaccine. Cell, 187, 813-813.e811.

  • Ng, Y.L., Salim, C.K.,Chu, J.J.H., 2021. Drug repurposing for COVID-19: Approaches, challenges and promising candidates. Pharmacol Ther, 228, 107930.

  • Petkovich, M.,Chambon, P., 2022. Retinoic acid receptors at 35 years. J Mol Endocrinol, 69, T13-t24.

  • Pushpakom, S., Iorio, F., Eyers, P.A., Escott, K.J., Hopper, S., Wells, A., Doig, A., Guilliams, T., Latimer, J., Mcnamee, C., Norris, A., Sanseau, P., Cavalla, D.,Pirmohamed, M., 2019. Drug repurposing: progress, challenges and recommendations. Nat Rev Drug Discov, 18, 41-58.

  • Ren, Y.S., Li, H.L., Piao, X.H., Yang, Z.Y., Wang, S.M.,Ge, Y.W., 2021. Drug affinity responsive target stability (DARTS) accelerated small molecules target discovery: Principles and application. Biochem Pharmacol, 194, 114798.

  • Schubert, M.,Germain, P., 2023. Retinoic Acid and Retinoid X Receptors. Cells, 12.

  • Shuvalova, E., Shuvalov, A., Al Sheikh, W., Ivanov, A.V., Biziaev, N., Egorova, T.V., Dmitriev, S.E., Terenin, I.M.,Alkalaeva, E., 2025. Eukaryotic initiation factors eIF4F and eIF4B promote translation termination upon closed-loop formation. Nucleic Acids Res, 53, gkaf161.

  • Silva, L.A.,Dermody, T.S., 2017. Chikungunya virus: epidemiology, replication, disease mechanisms, and prospective intervention strategies. J Clin Invest, 127, 737-749.

  • Tong, L., Wang, L., Liao, S., Xiao, X., Qu, J., Wu, C., Zhu, Y., Tai, W., Huang, Y., Wang, P., Li, L., Zhang, R., Xiang, Y.,Cheng, G., 2022. A Retinol Derivative Inhibits SARS-CoV-2 Infection by Interrupting Spike-Mediated Cellular Entry. mBio, 13, e0148522.

  • Wang, M., Wang, L., Leng, P., Guo, J.,Zhou, H., 2024. Drugs targeting structural and nonstructural proteins of the chikungunya virus: A review. Int J Biol Macromol, 262, 129949.

  • Wang, T.Y., Sun, Y.,Tang, Y.D., 2025. Re-emergence of chikungunya virus in China by 2025: What we know and what to do? PLoS Pathog, 21, e1013556.

  • Wu, B., Yu, C., Lin, Y., Zhao, P., Qi, Z.,Qian, X., 2025. Verteporfin Inhibits Severe Fever with Thrombocytopenia Syndrome Virus Infection via Inducing the Degradation of the Viral Gn Protein. Pharmaceutics, 17, 434.

  • Zhang, Y., Wu, J., Cheng, X., Yang, Y., Wang, X., Zhao, X., Wang, X., Ouyang, H., Ai, J.,Zhang, W., 2026. Global resurgence of Chikungunya virus: outbreak drivers and emerging solutions. Emerg Microbes Infect, 15, 2603714.

  • Zheng, X., He, Y., Xia, B., Tang, W., Zhang, C., Wang, D., Tang, H., Zhao, P., Peng, H.,Liu, Y., 2024. Etravirine Prevents West Nile Virus and Chikungunya Virus Infection Both In Vitro and In Vivo by Inhibiting Viral Replication. Pharmaceutics, 16, 1111.